- About Us
- Our Approach
- Patients & Providers
- Science & Pipeline
Employ creative, outside-the-box strategies to overcome drug development and regulatory challenges and bring life-changing therapeutics to people with rare diseases.
To give every promising rare disease therapy candidate a fighting chance to reach patients and improve their quality of life.
Who We Are
We are a rare disease therapeutics company leading with science to make life-changing therapeutics available to patients with significant unmet needs. We involve key thought leaders, physicians, patients, care partners and advocacy groups in all of our clinical and regulatory development strategies.
With a keen understanding that drug development often requires creative solutions, we have the insight and expertise to forge new pathways to success that others have missed. By following the data without bias, our transparent narratives and common-sense perspective have successfully overcome complex development challenges to make much-needed therapies available to patients.
Nimble and dauntless, we push boundaries beyond what is thought to be possible and advance new therapies that have the potential to bring meaningful improvement to patients’ lives.
About Zevra Therapeutics
Nimble and determined, Zevra pushes boundaries beyond what is possible to advance new therapies that meaningfully improve patients’ lives.
The Zevra Story
Zevra is Greek for zebra, the official symbol of rare disease. The idea came from the medical school adage, “when you hear hoofbeats, don’t expect a zebra,” meaning, illness is most likely caused by something common, not rare.
However, in a world of horses, we are paying attention to the zebras, people with rare diseases. In honor of our commitment, we named our company for them.
The distinct stripes of an individual zebra symbolize the many rare diseases represented by these patient communities.
To us, like the infinite, unique possibilities of a zebra’s stripes, we believe there are boundless pathways for therapeutics to achieve regulatory approval and reach people with rare diseases.
Zevra is a team of expert scientists, patient advocates, development strategists, commercialization specialists, and business development gurus with a proven record of bringing new therapies to patients.
https://zevra.com/wp-content/uploads/Zevra_Headshots-Neil.png 429 319 Emily Hennes /wp-content/uploads/logo.svg Emily Hennes2023-10-09 12:08:342023-10-09 12:12:29Neil F. McFarlane
President & Chief Executive Officer
https://zevra.com/wp-content/uploads/Zevra_Headshots-Christal.png 428 319 eallison /wp-content/uploads/logo.svg eallison2022-12-29 12:53:262023-10-09 12:14:32Christal M.M. Mickle
Chief Development Officer; Co-Founder
https://zevra.com/wp-content/uploads/Zevra_Headshots-LeDuane.png 429 320 eallison /wp-content/uploads/logo.svg eallison2022-12-29 12:52:422023-03-17 12:40:31R. LaDuane Clifton, MBA, CPA
Chief Financial Officer, Secretary, & Treasurer
https://zevra.com/wp-content/uploads/Zevra_Headshots-Sven.png 429 319 eallison /wp-content/uploads/logo.svg eallison2022-12-29 12:52:582023-03-17 12:40:51Sven Guenther, Ph.D.
Chief Scientific Officer
https://zevra.com/wp-content/uploads/Zevra_Headshots-Josh.png 428 319 David Anderson /wp-content/uploads/logo.svg David Anderson2023-01-30 13:38:522023-03-17 12:42:38Joshua Schafer
Chief Commercial Officer & Executive Vice President, Business Development
https://zevra.com/wp-content/uploads/Zevra_Headshots-Rene.png 428 320 eallison /wp-content/uploads/logo.svg eallison2022-12-29 12:54:202023-03-17 12:43:26Rene A. Braeckman, Ph.D.
Senior Vice President, Clinical Development
https://zevra.com/wp-content/uploads/Zevra_Headshots-Dan.png 428 320 David Anderson /wp-content/uploads/logo.svg David Anderson2023-02-03 09:18:012023-03-17 12:44:30Daniel Gallo, Ph.D.
Senior Vice President, Medical Affairs and Advocacy
https://zevra.com/wp-content/uploads/Zevra_Headshots-Christopher.png 428 319 eallison /wp-content/uploads/logo.svg eallison2022-12-29 12:54:022023-03-17 12:44:57Christopher M. Lauderback, PhD
Senior Vice President, Manufacturing
Board of Directors
/wp-content/uploads/logo.svg 0 0 eallison /wp-content/uploads/logo.svg eallison2022-12-29 12:55:412023-05-06 18:02:03Tamara A. (Seymour) Favorito
Board Chair and Chair of Audit Committee
/wp-content/uploads/logo.svg 0 0 Emily Hennes /wp-content/uploads/logo.svg Emily Hennes2023-08-04 12:06:062023-08-04 12:41:43Thomas D. Anderson
/wp-content/uploads/logo.svg 0 0 David Anderson /wp-content/uploads/logo.svg David Anderson2023-04-25 17:42:592023-05-05 14:42:57John B. Bode
Board Member & Chair, Nominating & Corporate Governance Committee
/wp-content/uploads/logo.svg 0 0 David Anderson /wp-content/uploads/logo.svg David Anderson2023-04-25 17:40:342023-04-26 12:45:39Douglas W. Calder
/wp-content/uploads/logo.svg 0 0 David Anderson /wp-content/uploads/logo.svg David Anderson2023-04-26 12:20:592023-05-11 08:26:05Wendy Dixon, Ph.D.
Board Member & Chair, Compensation Committee
/wp-content/uploads/logo.svg 0 0 Emily Hennes /wp-content/uploads/logo.svg Emily Hennes2023-10-09 12:05:382023-10-09 12:10:17Neil F. McFarlane
/wp-content/uploads/logo.svg 0 0 David Anderson /wp-content/uploads/logo.svg David Anderson2023-04-25 17:39:192023-04-26 12:46:06Corey Watton